Dermastyle S.R.L.

The Dermatovenerology department at Dermastyle S.R.L. concentrates on immune system diseases, with a particular focus on Atopic Dermatitis. Ongoing studies aim to test new therapeutic approaches that could better control symptoms and improve quality of life.

• Evaluation of the novel biologic rocatinlimab for moderate‑to‑severe eczema
• Use of the Eczema Area and Severity Index (EASI) to measure treatment impact
• Long‑term safety and effectiveness assessment in adolescent patients
• Investigation of underlying immune mechanisms driving atopic skin inflammation

Located in Bucharest, Romania, the site conducts its trials with a dedicated investigator team, seeking to bring advanced therapies to those affected by atopic dermatitis.